Logo image of RMO

ROMEO POWER INC (RMO) Stock Fundamental Analysis

NYSE:RMO - New York Stock Exchange, Inc. - US7761531083 - Common Stock - Currency: USD

0.35  -0.01 (-3.18%)

After market: 0.37 +0.02 (+5.71%)

Fundamental Rating

1

RMO gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 96 industry peers in the Electrical Equipment industry. RMO may be in some trouble as it scores bad on both profitability and health. RMO is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RMO had negative earnings in the past year.
In the past year RMO has reported a negative cash flow from operations.
RMO Yearly Net Income VS EBIT VS OCF VS FCFRMO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 -50M -100M -150M -200M

1.2 Ratios

Industry RankSector Rank
ROA -64.31%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
RMO Yearly ROA, ROE, ROICRMO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -10 -20

1.3 Margins

Industry RankSector Rank
OM -475.13%
PM (TTM) -550.95%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RMO Yearly Profit, Operating, Gross MarginsRMO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 -200 -400 -600

More info and screens

2

2. Health

2.1 Basic Checks

RMO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RMO has been increased compared to 1 year ago.
Compared to 1 year ago, RMO has a worse debt to assets ratio.
RMO Yearly Shares OutstandingRMO Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 20M 40M 60M 80M 100M
RMO Yearly Total Debt VS Total AssetsRMO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

RMO has an Altman-Z score of -2.30. This is a bad value and indicates that RMO is not financially healthy and even has some risk of bankruptcy.
RMO has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Altman-Z -2.3
ROIC/WACCN/A
WACC11.64%
RMO Yearly LT Debt VS Equity VS FCFRMO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 100M -100M 200M -200M

2.3 Liquidity

RMO has a Current Ratio of 3.02. This indicates that RMO is financially healthy and has no problem in meeting its short term obligations.
RMO has a Quick Ratio of 1.67. This is a normal value and indicates that RMO is financially healthy and should not expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 3.02
Quick Ratio 1.67
RMO Yearly Current Assets VS Current LiabilitesRMO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for RMO have decreased strongly by -469.12% in the last year.
RMO shows a strong growth in Revenue. In the last year, the Revenue has grown by 1525.71%.
EPS 1Y (TTM)-469.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.64%
Revenue 1Y (TTM)1525.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%518.68%

3.2 Future

Based on estimates for the next years, RMO will show a decrease in Earnings Per Share. The EPS will decrease by -0.83% on average per year.
RMO is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 162.71% yearly.
EPS Next Y-21.44%
EPS Next 2Y3.64%
EPS Next 3Y10.21%
EPS Next 5Y-0.83%
Revenue Next Year170.66%
Revenue Next 2Y204.73%
Revenue Next 3Y172.45%
Revenue Next 5Y162.71%

3.3 Evolution

RMO Yearly Revenue VS EstimatesRMO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
RMO Yearly EPS VS EstimatesRMO Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 0 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RMO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RMO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RMO Price Earnings VS Forward Price EarningsRMO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.2
RMO Per share dataRMO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1 -1 -1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y3.64%
EPS Next 3Y10.21%

More info and screens

0

5. Dividend

5.1 Amount

RMO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROMEO POWER INC

NYSE:RMO (10/14/2022, 8:04:01 PM)

After market: 0.37 +0.02 (+5.71%)

0.35

-0.01 (-3.18%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)08-01 2022-08-01/amc
Earnings (Next)11-14 2022-11-14/amc
Inst Owners0.01%
Inst Owner Change0%
Ins Owners12.8%
Ins Owner Change0%
Market Cap65.07M
Analysts45
Price Target1.84 (425.71%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.64%
Min EPS beat(2)-12.21%
Max EPS beat(2)17.49%
EPS beat(4)2
Avg EPS beat(4)5.57%
Min EPS beat(4)-29.95%
Max EPS beat(4)46.96%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-17.88%
Min Revenue beat(2)-46%
Max Revenue beat(2)10.24%
Revenue beat(4)3
Avg Revenue beat(4)3.94%
Min Revenue beat(4)-46%
Max Revenue beat(4)28.62%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.03
P/FCF N/A
P/OCF N/A
P/B 0.31
P/tB 0.31
EV/EBITDA -0.2
EPS(TTM)-1.02
EYN/A
EPS(NY)-0.78
Fwd EYN/A
FCF(TTM)-1.54
FCFYN/A
OCF(TTM)-1.25
OCFYN/A
SpS0.17
BVpS1.13
TBVpS1.13
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -64.31%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM -475.13%
PM (TTM) -550.95%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.01
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1624.62%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 161.93%
Current Ratio 3.02
Quick Ratio 1.67
Altman-Z -2.3
F-Score2
WACC11.64%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-469.12%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.64%
EPS Next Y-21.44%
EPS Next 2Y3.64%
EPS Next 3Y10.21%
EPS Next 5Y-0.83%
Revenue 1Y (TTM)1525.71%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%518.68%
Revenue Next Year170.66%
Revenue Next 2Y204.73%
Revenue Next 3Y172.45%
Revenue Next 5Y162.71%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-136370%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110230%
OCF growth 3YN/A
OCF growth 5YN/A